Patents by Inventor Nigel John Gooderham

Nigel John Gooderham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of highly vascular tumors
    Patent number: 6297225
    Abstract: A method of treating a patient having a highly vascular tumor includes administering a therapeutically effective amount of dextrin sulphate to the patient. The highly vascular tumor can be, for example, Kaposi's sarcoma. The treatment results in regression of the tumors and the improvement persists for a considerable time after completion of the treatment.
    Type: Grant
    Filed: September 22, 1999
    Date of Patent: October 2, 2001
    Assignee: M L Laboratories PLC
    Inventors: Donald Davies, Robert John Edwards, Nigel John Gooderham, Sunil Shaunak
  • Antiviral agent comprising CD4 and H2 histone
    Patent number: 5714462
    Abstract: The invention provides an agent against HIV and/or related viruses, comprising CD4 or a CD4-like substance and an H2 histone or an H2 histone-like protein. The content of the CD4 or CD4-like substance is preferably less than the antivirally effective dose of that substance alone. The invention also provides an H2 histone or an H2-like protein, for use in a method of medical treatment, in particular against HIV and/or related viruses, and also for use in the manufacture of a pharmaceutical composition against HIV and/or related viruses.
    Type: Grant
    Filed: December 30, 1994
    Date of Patent: February 3, 1998
    Assignee: ML Laboratories
    Inventors: Donald Selwyn Davies, Sunil Shaunak, Nigel John Gooderham, Robert John Edwards